Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endometrial Gene Expression with Progesterone After Mifepristone
NCT06616077Phase 1Completed
- Sponsor
- Reproductive Health Research Institute
- Start
- Jun 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of progesterone (4 arms), sponsored by Reproductive Health Research Institute. Primary endpoint: Endometrial Gene Expression Profile at 12 weeks. Started Jun 2022; status: completed.
02
Drugs
progesterone
Beyond the preview
Go deeper on NCT06616077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06616077.